Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04676334
Title CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib (CATCH-R)
Recruitment Enrolling by invitation
Gender both
Phase Phase III
Variant Requirements No
Sponsors Clovis Oncology, Inc.

peritoneum cancer

prostate cancer

fallopian tube cancer

Advanced Solid Tumor

ovarian cancer

ovary epithelial cancer



Age Groups: adult | senior
Covered Countries USA | ITA | ESP | CAN

No variant requirements are available.